CHMX · As filed with the SEC

NEXT-ChemX cash flow statement, by quarter

The statement as NEXT-ChemX presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Condensed Statements of Cash Flows (Unaudited) · USD

USD	Q2 2025^† 3 months ended Jun 30, 2025	Q1 2025 3 months ended Mar 31, 2025	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	(455,639)^†	(465,926)	(594,935)^†	(279,604)^†
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	38,691^†	38,780	151,116^†	(73,557)^†
Unrealized gain on trading securities	6,275^†	(8,699)	29,680^†	17,331^†
Changes in Operating Assets and Liabilities:
Net Cash from Operating Activities	(11,800)^†	31,570	3,000^†	28,040^†
Prepaid expenses	—	(12,635)	(13,298)^†	(60,448)^†
Accounts payable and accrued liabilities	111,940^†	209,975	(75,426)^†	196,931^†
Net cash provided by (used in) operating activities	(328,571)^†	(206,935)	(499,863)^†	(171,307)^†
FINANCING ACTIVITIES
Proceeds from Debt Issuance	350,000^†	145,000	—	—
Proceeds from Debt Issuance	—	0	0^†	0^†
Proceeds from Debt Issuance	—	—	539,004^†	206,000^†
Net cash provided by (used in) financing activities	350,000^†	145,000	527,024^†	206,000^†
Net increase (decrease) in cash	21,429^†	(61,935)	27,161^†	34,693^†
Cash, beginning of year	612	62,547	35,386	693
Cash, end of the period	22,041	612	62,457	35,386
NON-CASH INVESTING AND FINANCING ACTIVITIES
Conversion of loan, interest and debt to convertible note	—	—	—	0^†
Issuance of Preferred Stocks against Indebtedness	—	—	0^†	20^†

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.